A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Summary

The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of maintenance therapy (Week 52) among participants who were in clinical response to guselkumab at Week 12.

Timeline

Start

2024-03-13

Primary completion

2027-10-27

Completion

2028-07-12

Drugs

Indications